Scinai Fortifies CDMO Operations with Veteran Supply Chain Executive
Event summary
- Scinai appointed Eran Kuratz as Head of Supply Chain and Business Process Administration for its CDMO subsidiary on August 10, 2026
- Kuratz brings 30+ years of pharmaceutical and biotech supply chain experience from roles at Kamada, Gamida Cell, and PepsiCo-Frito-Lay
- Appointment follows Q1 2026 acquisition of Recipharm Israel, expanding Scinai's CDMO capabilities across Jerusalem and Yavne sites
- Kuratz will oversee integration of operations, enterprise systems, and cross-functional business processes
The big picture
Scinai's appointment of Kuratz underscores the operational complexities following its CDMO expansion through acquisition. The move reflects broader industry trends where biopharma companies are consolidating manufacturing capabilities to improve efficiency and scale. With $X in annual revenue from its CDMO business, Scinai is positioning itself as a formidable player in the contract manufacturing space, though integration risks remain.
What we're watching
- Integration Challenges
- How quickly Kuratz can unify Jerusalem and Yavne operations following Recipharm Israel acquisition...
- Scalability Strategy
- Whether Scinai's expanded CDMO platform can sustain growth while maintaining operational discipline...
- Commercial Reach
- The pace at which Recipharm AB collaboration drives international business for Scinai's CDMO services...